Here, we performed an extensive multi-omics study to discover and validate of HMGB2 as an early diagnostic and/or predictive marker of glioma progression and demonstrated one possible regulatory epigenetic mechanism of gene expression. This evidence concerns the gene HMGB2 and central nervous system cancer.